DXRX
NEUTRALDiaceutics PLC Announces Notice of AGM and Posting of Annual Report
The healthcare technology company announces the details of its upcoming annual general meeting and the availability of its annual report.
Diaceutics
140.00GBX
0.72%
Market Cap
118.33M
Volume
101.75k
89% of avg
P/E Ratio
0.70
EPS (TTM)
1.99
Beta
0.82
Day Range
139.00p - 142.00p
52 Week Range
106.00p140.00p151.00p
140.00p
Upcoming Events
DXRX
NEUTRALDiaceutics Director Sells Shares
The chair of Diaceutics PLC's spouse has sold a portion of their shareholding in the company.
DXRX
GOODDiaceutics Reports Strong Revenue Growth of 39% in FY 2024 Results
The diagnostic commercialisation company reported strong revenue growth and improved margins, with expectations to return to profitability in 2025, despite ongoing economic uncertainties.
DXRX
NEUTRALDiaceutics Announces PDMR Shareholding and Share Incentive Plan
The healthcare technology company announces changes to PDMR shareholdings and the implementation of a share incentive plan for employees.
DXRX
NEUTRALDiaceutics Announces Upcoming Results Presentation
The healthcare technology company announces plans to release its annual results and hold investor presentations.
DXRX
NEUTRALDiaceutics PLC Announces PDMR Shareholding and Share Incentive Plan
The healthcare technology company announces changes to its PDMR shareholdings and share incentive plan.
DXRX
VERY GOODDiaceutics Secures Lucrative PMx Contract Extension with Partner Therapeutics
The diagnostic commercialization company secures a lucrative contract extension with a major pharmaceutical partner, potentially worth up to £18.5 million in recurring service revenues over the next several years.
DXRX
NEUTRALDiaceutics PLC Announces Change in Shareholding
The diagnostic company has announced a change in its shareholder base, with Danske Bank A/S increasing its stake to 3.99% of the voting rights.
DXRX
NEUTRALDiaceutics Announces PDMR Share Purchases Under Incentive Plan
The diagnostic commercialisation company announces PDMR share purchases under its employee incentive plan.
DXRX
NEUTRALDiaceutics PLC Announces Director Share Purchase
The healthcare technology company announces a non-executive director has purchased a small number of shares, a routine regulatory disclosure.